PetIQ Inc. (NASDAQ: PETQ) shares fell sharply Monday as at least one analyst adjusted earnings expectations for the pet health products company and lowered stock price expectations.
Raymond James analyst Joseph Altobello maintained an Outperform on PetIQ and lowered the price target from $42 to $39.
Altobello reduced his 2019 adjusted EBITDA estimate ahead of the company’s release of fourth quarter and full-year 2018 results — and 2019 guidance — expected March 11.
Despite lowered expectations for adjusted earnings, Altobello cautioned against putting PetIQ stock in the doghouse just yet in a Friday note.
The continued Outperform rating reflects Raymond James’ belief that PetIQ remains positioned for double-digit net sales and earnings growth for the foreseeable future, the analyst said, adding that its acquisition of VIP Petcare was a good pickup.
Altobello’s net sales estimate of $609 million, representing an 18-percent year-over-year increase, remains unchanged.
The revised EBITDA estimate and resulting lower price target reflect a prior estimate that Altobello said was too aggressive. The new estimate “still implies fairly healthy upside” of over 30 percent from Friday’s closing stock price, he said.
PetIQ shares were down 8.69 percent at $27.02 at the close Monday.
10 Stocks To Watch For May 15, 2018
KeyBanc Upgrades Underappreciated Central Garden And Pet Co.
Latest Ratings for PETQ
|Mar 2019||Raymond James||Maintains||Outperform||Outperform|
|Nov 2018||Raymond James||Maintains||Outperform||Outperform|
|Sep 2018||Raymond James||Maintains||Outperform||Outperform|
View More Analyst Ratings for PETQ
View the Latest Analyst Ratings
See more from Benzinga
- Netflix, Spielberg Tussle Over Oscar Eligibility
- Baird: Long Ramp To Tesla Model Y Production Could Ease Cannibalization Concerns
- BMO Upgrades Hasbro, Eyeing Strong Box Office Tie-Ins
© 2019 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.